PROGRESS TOWARD THE DEVELOPMENT OF A LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE

被引:0
作者
MURPHY, BR
CROWE, JE
BUI, PT
ELKINS, WR
FIRESTONE, CY
CHANOCK, RM
LUBECK, MD
KARRON, R
CLEMENTS, ML
WRIGHT, PF
SIBER, GR
机构
[1] NIAID,BETHESDA,MD 20892
[2] WYETH AYERST RES,RADNOR,PA 19101
[3] JOHNS HOPKINS UNIV,BALTIMORE,MD 21205
[4] VANDERBILT UNIV,MED CTR,SCH MED,NASHVILLE,TN 37232
[5] MASSACHUSETTS PUBL HLTH BIOL LABS,BOSTON,MA 02130
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:274 / 274
页数:1
相关论文
共 50 条
  • [41] EVALUATION OF LIVE, ATTENUATED RESPIRATORY SYNCYTIAL VIRUS-VACCINES IN CHIMPANZEES
    BELSHE, RB
    RICHARDSON, LS
    LONDON, WT
    SLY, DL
    CHANOCK, RM
    CLINICAL RESEARCH, 1977, 25 (03): : A372 - A372
  • [42] Development of mRNA vaccines against respiratory syncytial virus (RSV)
    Qiu, Xirui
    Xu, Siyan
    Lu, Yang
    Luo, Zichen
    Yan, Yangtian
    Wang, Chuyue
    Ji, Jianjian
    CYTOKINE & GROWTH FACTOR REVIEWS, 2022, 68 : 37 - 53
  • [43] Respiratory Syncytial Virus (RSV) Update
    Krilov, Leonard R.
    Roberts Jr, Norbert
    VIRUSES-BASEL, 2022, 14 (10):
  • [44] Pathobiology of Respiratory Syncytial Virus (RSV)
    Tripp, Ralph A.
    McNamara, Paul S.
    VACCINES, 2020, 8 (03)
  • [45] Research Progress in Live Attenuated Brucella Vaccine Development
    Wang, Zhen
    Wu, Qingmin
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2013, 14 (10) : 887 - 896
  • [46] ISOLATION AND CHARACTERIZATION OF A HIGHLY ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE CANDIDATE BY MUTAGENESIS OF THE INCOMPLETELY ATTENUATED RSV A2 TS-1 NG-1 MUTANT VIRUS
    HSU, KHL
    CROWE, JE
    LUBECK, MD
    DAVIS, AR
    HUNG, PP
    CHANOCK, RM
    MURPHY, BR
    VACCINE, 1995, 13 (05) : 509 - 515
  • [47] LIVE RESPIRATORY SYNCYTIAL VIRUS-VACCINE ADMINISTERED PARENTERALLY
    BUYNAK, EB
    WEIBEL, RE
    MCLEAN, AA
    HILLEMAN, MR
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1978, 157 (04): : 636 - 642
  • [48] Implication of respiratory syncytial virus (RSV) F transgene sequence heterogeneity observed in Phase 1 evaluation of MEDI-534, a live attenuated parainfluenza type 3 vectored RSV vaccine
    Yang, Chin-Fen
    Wang, C. Kathy
    Malkin, Elissa
    Schickli, Jeanne H.
    Shambaugh, Cindy
    Zuo, Fengrong
    Galinski, Mark S.
    Dubovsky, Filip
    Tang, Roderick S.
    VACCINE, 2013, 31 (26) : 2822 - 2827
  • [49] The future of respiratory syncytial virus vaccine development
    Polack, FP
    Karron, RA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (01) : S65 - S73
  • [50] RESPIRATORY SYNCYTIAL VIRUS (RSV) OR ROUS-SARCOMA VIRUS (RSV)
    LINDHARDT, BO
    CHEST, 1995, 108 (01) : 292 - 292